Lasa Supergenerics has received an approval for raising funds up to extent of Rs 100 crore by way of offer, issue and allotment of equity shares to the existing shareholders of the company on rights basis (Right Issue). The Board of Directors of the company in its meeting held on January 06, 2018, approved the same.
Lasa Supergenerics manufactures and distributes chemicals. The company offers veterinary API products, animal feed ingredients, and reagents for therapeutic uses.